Resolve Morning After Sachets 5s
£2.34
out of stock
Effervescent granules.
Recommended for the relief of headache with gastric upset, particularly associated with over indulgence in food or drink or both.
Recommended for the relief of headache with gastric upset, particularly associated with over indulgence in food or drink or both.
| Each 8.09g sachet of granules contains: |
| Paracetamol 1000mg |
| Anhydrous Citric Acid 1185mg |
| Sodium Bicarbonate 808mg |
| Potassium Bicarbonate 715mg |
| Anhydrous Sodium Carbonate 153mg |
| Ascorbic Acid (Vitamin C) 30mg in a base containing Glucose (4g) |
For oral administration. Dissolve the contents of the sachet in a glass of water (150-200ml) before taking. Adults and children aged 16 years and over. One sachet every four hours as required. Do not take more than 4 sachets in any 24 hours. Not to be given to children under 16 years of age. The elderly may take the normal adult dose.
Know hypersensitivity to any of the ingredients. Hepatic or severe renal impairment. Patients on sodium restricted diets.
Concomitant use of other paracetamol-containing products should be avoided. Consult a doctor if taking warfarin.
The hazards of overdose are greater in those with non-cirrhotic alcoholic liver disease.
Sachet label: Immediate medical advice should be sought in the event of an overdose, even if you feel well. Do not take with other paracetamol-containing products. Contains paracetamol. Do not exceed the stated dose. If symptoms persist consult your doctor.
Carton label: Immediate medical advice should be sought in the event of an overdose even if you feel well, because of the risk of delayed, serious liver damage.
The anticoagulant effect of warfarin and other coumarins may be enhanced by prolonged regular use of paracetamol with increased risk of bleeding. Occasional doses have no significant effect. The hepatotoxicity of paracetamol may be potentiated by excessive intake of alcohol. The speed of absorption of paracetamol may be increased by metoclopramide or domperidone and absorption reduced by cholestyramine. These interactions are considered to be of unlikely clinical significance in acute use at the dosage regimen proposed. The acid neutralising capacity of the product may alter the absorption profile of pH specific drugs given concomitantly.
Epidemiological studies in human pregnancy have show no ill effects due to paracetamol used in the recommended dosage, and hence paracetamol is not contraindicated during pregnancy. However, patients should follow the advice of their doctor regarding its use. Paracetamol is excreted in breast milk but not in clinically significant amounts. Available published data do not contraindicate breast feeding. KEEP ALL MEDICINES SAFELY AWAY FROM CHILDREN.
Know hypersensitivity to any of the ingredients. Hepatic or severe renal impairment. Patients on sodium restricted diets.
Concomitant use of other paracetamol-containing products should be avoided. Consult a doctor if taking warfarin.
The hazards of overdose are greater in those with non-cirrhotic alcoholic liver disease.
Sachet label: Immediate medical advice should be sought in the event of an overdose, even if you feel well. Do not take with other paracetamol-containing products. Contains paracetamol. Do not exceed the stated dose. If symptoms persist consult your doctor.
Carton label: Immediate medical advice should be sought in the event of an overdose even if you feel well, because of the risk of delayed, serious liver damage.
The anticoagulant effect of warfarin and other coumarins may be enhanced by prolonged regular use of paracetamol with increased risk of bleeding. Occasional doses have no significant effect. The hepatotoxicity of paracetamol may be potentiated by excessive intake of alcohol. The speed of absorption of paracetamol may be increased by metoclopramide or domperidone and absorption reduced by cholestyramine. These interactions are considered to be of unlikely clinical significance in acute use at the dosage regimen proposed. The acid neutralising capacity of the product may alter the absorption profile of pH specific drugs given concomitantly.
Epidemiological studies in human pregnancy have show no ill effects due to paracetamol used in the recommended dosage, and hence paracetamol is not contraindicated during pregnancy. However, patients should follow the advice of their doctor regarding its use. Paracetamol is excreted in breast milk but not in clinically significant amounts. Available published data do not contraindicate breast feeding. KEEP ALL MEDICINES SAFELY AWAY FROM CHILDREN.
Click here to download the patient information leaflet for Resolve Morning After Sachets 5s
